West Pharmaceutical Services to Present at the 2008 Wachovia Securities Healthcare Conference

LIONVILLE, Pa., Jan. 24 West PharmaceuticalServices, Inc. (NYSE: WST) today announced that Donald E. Morel, Jr., Ph.D,Chairman and Chief Executive Officer, and William Federici, Chief FinancialOfficer, will be presenting at the 2008 Wachovia Securities HealthcareConference at 2:30 p.m. on January 30, 2008 in Boston, MA.

A copy of the corporate presentation document will be posted on theinvestor link of the Company's website at www.westpharma.com and the liveaudio webcast of the presentation will also be available through the website.A replay of the audio portion will be accessible on the Company's websitebeginning 3 hours after the actual presentation time and will be availableuntil March 1, 2008.

About West Pharmaceutical Services, Inc.

West Pharmaceutical Services, Inc. is a global manufacturer of componentsand systems for injectable drug delivery, including stoppers and seals forvials, and closures and disposable components used in syringe, IV and bloodcollection systems. The Company also provides products with application to thepersonal care, food and beverage markets. Headquartered in Lionville,Pennsylvania, West Pharmaceutical Services supports its partners and customersfrom 50 locations throughout North America, South America, Europe, Mexico,Japan, Asia and Australia. For more information, visit West atwww.westpharma.com.Contacts: Investors and Financial Media: West Pharmaceutical Services, Inc. Financial Dynamics Michael A. Anderson Evan Smith / Theresa Kelleher Vice President and Treasurer (212) 850-5600 (610) 594-3345 [email protected]

SOURCE West Pharmaceutical Services, Inc.

Latest Press Release on General News

Precision oncology company Flindr Therapeutics announces €20 million Series A financing to advance first-in-class small molecule inhibitors

V-Bio Ventures leads international syndicate which includes Johnson & Johnson Innovation – JJDC, Inc., QBIC Fund, Flanders Future Tech Fund, Curie Capital as well as seed investor...

Rett Syndrome Research Trust Partners with Vivalink to Shift Symptom Assessment Paradigms in Rett Syndrome

Vivalink's remote patient monitoring solutions accelerate research into rare neurological disorder CAMPBELL, Calif. , April 23, 2024 /PRNewswire/ -- Vivalink , a leading pro...

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

Debunking myths about Irritable Bowel Syndrome TORONTO , April 18, 2024 /PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating,...

Important step taken on the Canada Disability Benefit in Budget 2024, but funding falls short

More work must be done to lift Canadians with disabilities out of poverty TORONTO , April 17, 2024 /CNW/ - The federal government has taken an important step on the Canada Di...

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...